Britvic Buys Plant-based Nutrition Brand Plenish; Financial Terms Not Disclosed

Britvic plc (BVIC.L), a plant-based drinks brand, announced Tuesday the acquisition of Plenish, which offers a range of organic, clean label, plant-based beverages across plant-based milks, cold-pressed juices and functional shots. The financial terms of the deal were not disclosed.

Plenish, which was founded in 2012 as a direct-to-consumer brand, has since expanded into retail distribution. Kara Rosen, the founder of Plenish, and her team will join Britvic.

Britvic expects the acquisition of Plenish brand, which uses ingredients sourced from sustainable, organic farms and no additives, gives it access to a fast-growing category. The acquisition is directly aligned to the group strategic priorities of Accessing New Spaces and Healthier People, Healthier Planet.

The company said the deal is strategically important, but the immediate value of the transaction is not material enough to impact adjusted EBIT in 2021.

Rosen said, "I started Plenish nine years ago in my kitchen to help make it easy and delicious for people to improve their health and make a positive impact for the planet. Our plant-based drinks are still made like I originally made them at home - with best in class ingredients sourced from sustainable, organic farms and no additives."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Boeing expects Europe's commercial aviation fleet to need 8,705 new airplanes through 2040 to cater to the growing leisure travel market in the region and fleet replacements with more fuel-efficient models, according to the Boeing's 2021 Commercial Market Outlook (CMO), an annual forecast of long-term demand for commercial airplanes and services. The U.S. Food and Drug Administration authorized marketing of a software developed by Paige.AI, a provider of AI-based digital diagnostics, which could help pathologists to identify prostate cancer. The software, called Paige Prostate, is the first and only artificial intelligence or AI-based pathology product to receive FDA approval for in vitro diagnostic or IVD use in detecting cancer... General Mills (GIS) said its first-quarter top- and bottom-line results were ahead of its expectations. The company also reaffirmed its fiscal 2022 outlook. Looking forward, General Mills anticipates changes in consumer behaviors driven by the COVID-19 pandemic will result in ongoing elevated consumer...
Follow RTT